04 Dec. 2023
What is Cardio-nephrology?
This area encompasses products that treat or diagnose heart failure and chronic renal failure. Heart failure is defined as the inability of the heart to maintain cardiac output sufficient to meet the body's energy needs. Chronic renal failure is defined as the gradual, significant and permanent impairment of kidney function. It’s characterised by progressive destruction of kidney tissue.
Vetoquinol-supported research shows the two conditions are linked. And we believe they should form the same clinical picture.
Vetoquinol's cardio-nephrology range and expertise
Vetoquinol has long invested in cardiology. We also support key opinion leaders in their research.
In 2015, we launched Vetoquinol's cardio-nephrology range with UpCard®. This innovative drug was a genuine breakthrough in the treatment of congestive heart failure.
• Wide product range - We now offer five products in Vetoquinol's cardio-nephrology range. Ours is the most comprehensive product range of all animal health companies.
• Wide geographic distribution - Vetoquinol's cardio-nephrology range is available in Europe, North America, Asia and Oceania.
• Highly innovative products - Every product in Vetoquinol's cardio-nephrology range is innovative. Whether it’s a new dosage, mode of action or clinical effect, our products are a vital part of the veterinary armamentarium.
• Expertise - We’ve forged links with many experts in the field of cardio-nephrology. This includes practitioners and researchers who help us discover therapeutic advances in this rapidly developing area.
Our cardio-nephrology brand portfolio:
UpCard®, Prilium®, Ipakitine®/Epakitine®, Azodyl® and Rubenal®
These pages are general information pages of the Vetoquinol Group. Product ranges are tailored to accommodate local demand and regulatory requirements which may change from one country to the next. For further information about the products in accordance with applicable national regulations, please refer to the Vetoquinol website for your country. The information provided depends on national registrations. The technical information is only accessible to authorised persons.